Table 3.

Table showing mean change in axial length and refraction of atropine 0.01% treated eyes and placebo treated eyes

Final	Treatment group		Control group		t	P
	Mean	SD	Mean	SD
Axial length
OD	0.115	0.11	0.303	0.12	9.8822	< 0.0001
OS	0.115	0.127	0.306	0.13	8.9181	< 0.0001
Refraction
OD	0.29	0.31	0.876	0.217	13.1466	< 0.0001
OS	0.36	0.308	0.897	0.238	11.7239	< 0.0001

Mean increase in axial length of group 1 is 0.115 mm and that of group 2 is 0.32 mm. Mean increase in refraction of group 1 is−0.30 D and that of group 2 is−0.88 D showing significant change in axial length and refraction